SARS-CoV-2 specific T cell immunity in spike protein antibody negative MS patients after vaccination

被引:0
|
作者
Goedel, C. [1 ]
Bartalis, A. [2 ]
Sack, U. [3 ]
Boldt, A. [3 ]
Bergh, F. Then [2 ]
机构
[1] Univ Hosp Leipzig, Dept Neurol, Leipzig, Germany
[2] Univ Leipzig, Dept Neurol, Leipzig, Germany
[3] Univ Hosp Leipzig, Inst Clin Immunol, Leipzig, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EP1090
引用
收藏
页码:865 / 866
页数:2
相关论文
共 50 条
  • [1] Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination
    Horndler, Lydia
    Delgado, Pilar
    Romero-Pinedo, Salvador
    Quesada, Marina
    Balabanov, Ivaylo
    Laguna-Goya, Rocio
    Almendro-Vazquez, Patricia
    Llamas, Miguel A.
    Fresno, Manuel
    Paz-Artal, Estela
    van Santen, Hisse M.
    Alvarez-Fernandez, Stela
    Olmo, Asuncion
    Alarcon, Balbino
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] SARS-CoV-2 spike antibody and longterm T cell responses in MS patients on Fingolimod and Ocrelizumab following SARS-CoV-2 mRNA vaccine
    Saxena, Shrishti
    Zhirova, Alena
    Krishnan, Rajesh
    Gopalakrishnan, Niveditha
    Solberg, Alyssa
    Conway, Sarah
    Chitnis, Tanjua
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1057 - 1058
  • [3] SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan
    Kanai, Daisuke
    Wakui, Hiromichi
    Haze, Tatsuya
    Azushima, Kengo
    Kinguchi, Sho
    Tsukamoto, Shunichiro
    Kanaoka, Tomohiko
    Urate, Shingo
    Toya, Yoshiyuki
    Hirawa, Nobuhito
    Kato, Hideaki
    Watanabe, Fumimasa
    Hanaoka, Kanako
    Hanaoka, Masaaki
    Mitsuhashi, Hiroshi
    Yamaguchi, Satoshi
    Ohnishi, Toshimasa
    Tamura, Kouichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (10) : 988 - 996
  • [4] SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan
    Daisuke Kanai
    Hiromichi Wakui
    Tatsuya Haze
    Kengo Azushima
    Sho Kinguchi
    Shunichiro Tsukamoto
    Tomohiko Kanaoka
    Shingo Urate
    Yoshiyuki Toya
    Nobuhito Hirawa
    Hideaki Kato
    Fumimasa Watanabe
    Kanako Hanaoka
    Masaaki Hanaoka
    Hiroshi Mitsuhashi
    Satoshi Yamaguchi
    Toshimasa Ohnishi
    Kouichi Tamura
    Clinical and Experimental Nephrology, 2022, 26 : 988 - 996
  • [5] Emergence of SARS-CoV-2 spike protein at the vaccination site
    Beck, Annika
    Dietenberger, Hanna
    Kunz, Sebastian N.
    Mellert, Kevin
    Moeller, Peter
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (03)
  • [6] Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
    Lim, Sean H.
    Campbell, Nicola
    Johnson, Marina
    Joseph-Pietras, Debora
    Collins, Graham P.
    O'Callaghan, Ann
    Fox, Christopher P.
    Ahearne, Matthew
    Johnson, Peter W. M.
    Goldblatt, David
    Davies, Andrew J.
    LANCET HAEMATOLOGY, 2021, 8 (08): : E542 - E544
  • [7] T cell immunity to SARS-CoV-2
    Niessl, Julia
    Sekine, Takuya
    Buggert, Marcus
    SEMINARS IN IMMUNOLOGY, 2021, 55
  • [8] T cell immunity to SARS-CoV-2 following natural infection and vaccination
    DiPiazza, Anthony T.
    Graham, Barney S.
    Ruckwardt, Tracy J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 211 - 217
  • [9] Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients
    How, Joan
    Gallagher, Kathleen M. E.
    Liu, Yiwen
    Katsis, Katelin
    Elder, Eva L.
    Larson, Rebecca C.
    Leick, Mark B.
    Neuberg, Donna
    Maus, Marcela V.
    Hobbs, Gabriela S.
    LEUKEMIA, 2022, 36 (04) : 1176 - 1179
  • [10] Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients
    Joan How
    Kathleen M. E. Gallagher
    Yiwen Liu
    Katelin Katsis
    Eva L. Elder
    Rebecca C. Larson
    Mark B. Leick
    Donna Neuberg
    Marcela V. Maus
    Gabriela S. Hobbs
    Leukemia, 2022, 36 : 1176 - 1179